Cargando…

P1413: DOES TOCILIZUMAB INCREASE THE RISK OF INFECTIONS IN PATIENTS UNDERGOING CAR-T THERAPY?

Detalles Bibliográficos
Autores principales:	Greenhalgh, Sophie, Asslan, Mona, Dignan, Fiona, Iqbal, Shahid, Norman, Jane, Bokhary, Mahmoud, Calvente Rubio, Lourdes, Davies, Elizabeth, Henry, Mark, Brice, Katie, Mannion, Lindsey, Tholouli, Eleni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430511/ http://dx.doi.org/10.1097/01.HS9.0000972540.84358.45

Ejemplares similares

1413. Skin microbiome: The Profile of Organisms and the Effect of Skin Decolonization.
por: Fernández-Rodríguez, Diana, et al.
Publicado: (2023)

1413. Effect of Automated Identification of Antimicrobial Stewardship Opportunities for Urinary Tract Infections
por: Deri, Connor, et al.
Publicado: (2021)

Multi-frequency VLBI observations of PKS 1413+135: a very young radio galaxy
por: Perlman, E S, et al.
Publicado: (1996)

El Hospital del Estudio (asistencia y hospitalidad de la Universidad de Salamanca), 1413–1810
por: Rowold, Katharina
Publicado: (1995)

Novel Pathogenic Variant of SPAST (c.1413+4A>G) in a Patient with Hereditary Spastic Paraplegia
por: Yang, Jiwon, et al.
Publicado: (2019)

1413. Trends in Risk of Respiratory Syncytial Virus Hospitalizations in Preterm Infants Over a 10-Year Period
por: Kong, Amanda M, et al.
Publicado: (2020)

High-quality permanent draft genome sequence of the Parapiptadenia rigida-nodulating Burkholderia sp. strain UYPR1.413
por: De Meyer, Sofie E, et al.
Publicado: (2015)

Draft Genome Sequence of a Methicillin-Resistant Staphylococcus aureus ST1413 Strain for Studying Genetic Mechanisms of Antibiotic Resistance
por: Marasa, Bernard S., et al.
Publicado: (2014)

1413. Surveillance of Variant Creutzfeldt Jakob Disease, Based on the Non-confirmatory Diagnostic Criteria of the EU Case Definition, Greece, 2014–2018
por: Dougas, Georgios, et al.
Publicado: (2019)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
por: Si, Stephanie, et al.
Publicado: (2020)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
por: Caimi, Paolo F., et al.
Publicado: (2021)

P1413: TRANSCRIPTION FACTOR-DRIVEN COORDINATION OF CELL CYCLE EXIT AND SPECIFICATION OF CELL IDENTITY IN VIVO DURING GRANULOCYTIC DIFFERENTIATION - IN MEMORIAM PROF. NIELS BORREGAARD
por: Theilgaard-Mönch, K., et al.
Publicado: (2022)

Which endometrial preparation protocol provides better pregnancy and perinatal outcomes for endometriosis patients in frozen-thawed embryo transfer cycles? A retrospective study on 1413 patients
por: Guo, Yaxin, et al.
Publicado: (2023)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia
por: Zhang, Yinqiang, et al.
Publicado: (2022)

Correction: Howe et al. “Effects of Long Chain Omega-3 Polyunsaturated Fatty Acids on Brain Function in Mildly Hypertensive Older Adults” Nutrients 2018, 10, 1413
por: Howe, Peter R. C., et al.
Publicado: (2019)

P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY
por: Yokoyama, Shota, et al.
Publicado: (2023)

SARS-CoV-2 infection in aplastic anemia
por: Avenoso, Daniele, et al.
Publicado: (2021)

The role of tocilizumab in the treatment of post‐transfusion hyperhaemolysis
por: Desai, Naeem, et al.
Publicado: (2023)

Raspbuggy, a programmable WiFi model car
por: COPY, Brice
Publicado: (2015)

1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies
por: Kibathi, Lilian, et al.
Publicado: (2018)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma
por: Roddie, Claire, et al.
Publicado: (2023)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021)

Tocilizumab: Neutropenia: case report
Publicado: (2020)

Günstige Effekte von Tocilizumab
por: Diener, Hans-Christoph
Publicado: (2020)

Papulopustular Rash Due to Tocilizumab
por: Kohro-Kawata, Junko, et al.
Publicado: (2019)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Tocilizumab ohne überzeugende Wirkung
por: Diener, Hans-Christoph
Publicado: (2021)

Cases of pancreatitis reported with tocilizumab
Publicado: (2021)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Tocilizumab: Neutropenia: case report
Publicado: (2021)

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
por: Lauper, Kim, et al.
Publicado: (2018)

Brucellosis: An Elusive Backyard Agent
por: Rizvi, Zain, et al.
Publicado: (2020)

“Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience”, a retrospective study-original article
por: Chachar, Aijaz Zeeshan Khan, et al.
Publicado: (2021)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9rg167un194iml47edec4apeu